Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $361.12 | 8 | 91.2% |
| Education | $34.95 | 1 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $131.15 | 3 | $0 (2024) |
| LEO Pharma Inc. | $82.63 | 2 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $60.60 | 1 | $0 (2018) |
| Celgene Corporation | $46.00 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $40.74 | 1 | $0 (2018) |
| PFIZER INC. | $34.95 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.73 | 2 | Incyte Corporation ($59.73) |
| 2023 | $52.08 | 1 | Incyte Corporation ($52.08) |
| 2022 | $120.92 | 3 | LEO Pharma Inc. ($66.63) |
| 2018 | $147.34 | 3 | Ortho Dermatologics, a division of Bausch Health US, LLC ($60.60) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/20/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $52.08 | General |
| Category: Dermatology | ||||||
| 10/21/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Dermatology | ||||||
| 10/20/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $66.63 | General |
| Category: DERMATOLOGY | ||||||
| 05/27/2022 | PFIZER INC. | EUCRISA (Drug) | Education | In-kind items and services | $34.95 | General |
| Category: DERMATOLOGY | ||||||
| 10/20/2018 | Celgene Corporation | Otezla (Drug) | Food and Beverage | Cash or cash equivalent | $46.00 | General |
| Category: Dermatology | ||||||
| 10/20/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $40.74 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2018 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $60.60 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,259 | 2,017 | $411,200 | $86,253 |
| 2022 | 16 | 1,115 | 1,697 | $374,870 | $82,264 |
| 2021 | 19 | 1,060 | 1,609 | $336,155 | $77,327 |
| 2020 | 15 | 923 | 1,393 | $294,885 | $63,011 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 306 | $93,330 | $24,254 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 260 | $55,900 | $14,370 | 25.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 208 | 238 | $57,120 | $9,070 | 15.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 68 | 81 | $31,995 | $5,861 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $20,000 | $4,203 | 21.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 55 | 59 | $20,945 | $3,905 | 18.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 155 | 766 | $19,150 | $3,679 | 19.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 23 | 26 | $15,470 | $3,124 | 20.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $11,605 | $2,570 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $10,590 | $2,370 | 22.4% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 27 | 29 | $12,035 | $1,868 | 15.5% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 27 | 29 | $10,440 | $1,663 | 15.9% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 19 | 19 | $8,265 | $1,653 | 20.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 18 | 19 | $8,170 | $1,563 | 19.1% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $7,200 | $1,437 | 20.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 36 | $6,480 | $1,370 | 21.1% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $6,305 | $1,281 | 20.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $10,200 | $1,131 | 11.1% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 13 | 16 | $6,000 | $880.50 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 250 | $68,040 | $19,320 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 226 | 265 | $49,445 | $15,232 | 30.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 153 | 176 | $41,360 | $6,342 | 15.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 62 | 84 | $32,760 | $6,288 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $22,145 | $5,705 | 25.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 17 | 23 | $23,920 | $5,245 | 21.9% |
About Dr. Susan Massick, MD
Dr. Susan Massick, MD is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144202490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Massick, MD has received a total of $396.07 in payments from pharmaceutical and medical device companies, with $75.73 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($361.12).
As a Medicare-enrolled provider, Massick has provided services to 4,357 Medicare beneficiaries, totaling 6,716 services with total Medicare billing of $308,856. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 11/14/2005
- Last Updated 07/02/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1144202490
Products in Payments
- OPZELURA (Drug) $131.15
- ADBRY (Biological) $82.63
- SILIQ (Drug) $60.60
- Otezla (Drug) $46.00
- COSENTYX (Biological) $40.74
- EUCRISA (Drug) $34.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506